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Key Points: 
 
• Nbeal2 interacts with Dock7, Sec16a and Vac14 and missense variants 
causing Gray Platelet Syndrome disrupt the binding of Dock7 and Vac14. 
• The level of the α-granule protein Dock7 in platelets from Nbeal2-/- mice and 
GPS cases is reduced and its signaling pathway is dysregulated. 
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Abstract 
Mutations in NBEAL2, the gene encoding the scaffolding protein Nbeal2 are causal of 
Gray Platelet Syndrome (GPS), a rare recessive bleeding disorder characterized by 
platelets lacking α-granules and progressive marrow fibrosis. We present here the 
interactome of Nbeal2 with additional validation by reverse immunoprecipitation of 
Dock7, Sec16a and Vac14 as interactors of Nbeal2. We show that GPS-causing 
mutations in its BEACH domain have profound and possible effects on the interaction 
with Dock7 and Vac14, respectively. Proximity ligation assays show that these two 
proteins are physically proximal to Nbeal2 in human megakaryocytes. In addition, we 
demonstrate that Nbeal2 is primarily localized in the cytoplasm and Dock7 on the 
membrane of or in α-granules. Interestingly, platelets from GPS cases and Nbeal2-/- 
mice are almost devoid of Dock7 resulting in a profound dysregulation of its signaling 
pathway, leading to defective actin polymerization, platelet activation and shape 
change. This study shows for the first time proteins interacting with Nbeal2 and 
points to the dysregulation of the canonical signaling pathway of Dock7 as a possible 
cause of the aberrant formation of platelets in GPS cases and Nbeal2 deficient mice.  
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Introduction 
Cellular secretion is a key biological event involved in many physiological processes 
including hemostasis 1,2. Secretory cells store granules, which are released according 
to predetermined temporal and spatial programs 3. The function of secretory cells is to 
a large extent linked to their types of granules, their content and the signaling events 
leading to secretion. Therefore the ontology and homeostasis of granules must be 
highly regulated, i.e. from the formation of the vesicles themselves and cargo sorting 
through cytoplasmic maintenance of formed vesicles and eventual exocytosis 4,5.  
Blood platelets are anucleated secretory cells originating from megakaryocytes (MKs) 
6
. Their primary role is in hemostasis 7, but they are also relevant in other patho-
physiological pathways 8-12. Platelet function is mediated by the release of their three 
types of granules upon vascular injury 13. Aberrations in any of these three granule 
types lead to inability of platelets to sustain hemostasis, resulting in bleeding 14. 
Defects in lysosomes are observed in Chediak-Higashi Syndrome and caused by 
mutations in LYST encoding a member of the family of Beige and Chediak-Higashi 
(BEACH)-domain (BEACH hereafter) containing proteins 15. Aberrations of platelet 
δ-granules are observed in Hermansky-Pudlak syndrome caused by mutations in 11 
genes encoding proteins with roles in the formation and trafficking of granules 16. 
Haploinsufficiency of another BEACH family member, Neurobeachin (NBEA), is 
associated with severe autism and atypical δ-granules in humans 17 and Nbea 
heterozygous mice 18.  
The α-granules are the most abundant organelles and granules in platelets. They 
contain hundreds of proteins with important functions in hemostasis and wound 
healing 8-12,19. Loss of function variants of the BEACH-domain gene NBEAL2 in Gray 
Platelet Syndrome (GPS) cases leads to absence of platelet α-granules 20-23. Nbeal2-/- 
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mice present with a faithful copy of human GPS with the typical large platelets of 
grayish appearance and interestingly neutrophils and mast cells are also dysfunctional 
24,25
. In vivo studies highlight the role of Nbeal2 beyond hemostasis, particularly in 
inflammation, innate immunity and cancer 24,26-28. However, the molecular function of 
Nbeal2 protein has not been explored. 
The BEACH proteins Lyst, Nbea and Nbeal2 are deemed essential for molecular 
processes underlying the formation, retention and secretion of the three types of 
granules in platelets 29. All nine BEACH genes encode large proteins between 2,000 – 
4,500 residues containing the Armadillo-type, Concanavalin-A lectin, Pleckstrin 
Homology (PH) and WD40 repeat domains in addition to the typical BEACH domain 
29
. This domain of approximately 35 kDa is unique to the BEACH family, highly 
conserved in eukaryotes and does not share sequence homology with other proteins 15. 
It is characterized by a unique hydrophobic secondary structure that cannot be 
classified as either β-strands or random coils 30 and strongly interacts with its 
neighboring PH domain but the significance of this interaction remains elusive 31.  
Here we use expression of Nbeal2 domains in human cells to define its proximal 
interactome with confirmation of Dock7, Sec16a and Vac14 as Nbeal2 binding 
partners by different biochemical and cellular approaches. We show that GPS-causing 
mutations strongly reduce the interaction of Dock7 with the BEACH domain and 
platelets from Nbeal2-/- mice and GPS patients are nearly devoid of Dock7 with a 
direct impact on platelet function. 
 
Material and Methods 
Short descriptions of the methods used are provided in this section and complete 
details are given in supplemental methods. 
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Cell culture and stable clones  
Human Embryonic Kidney 293T cells (HEK) and CHRF-288 cells (CHRF) were 
cultured following AATC procedures. Stable transfectants ectopically expressing the 
protein domains under study were generated by infection with lentiviral particles. 
HEK were transduced at a Multiplicity Of Infection (MOI) of 10 Transducing Units 
(TU) per cell in the presence of 1 μg/mL polybrene. CHRF were transduced at an 
MOI of 50 TU/cell in the presence of 1 μg/mL protamine sulfate. 
  
Tandem affinity purification 
Cells were collected, washed twice with cold PBS and pellets were snap-frozen on 
dry-ice and kept at -80ºC until immunoprecipitation. Pellets were resuspended with 
lysis buffer containing 0.1% NP-40 and protease inhibitor cocktail. Tandem affinity 
purification and sample preparation for mass spectrometry analysis were performed as 
previously described 32. 
 
Mass spectrometry and data analysis 
Peptides were re-dissolved in 0.5% formic acid and analysed with on-line nano liquid 
chromatography tandem mass spectrometry on an LTQ FT mass spectrometer 
(Thermo-Fisher Scientific) coupled with an Ultimate 3000 Nano/Capillary LC System 
(Dionex). Proteins frequently identified from tandem affinity purifications of 
unrelated targets in embryonic stem cells were discarded.  
The mass spectrometry proteomics data can be retrieved from the ProteomeXchange 
Consortium via the PRIDE 33 partner repository with the dataset identifier 
PXD006091. 
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Immunoprecipitation of endogenous proteins 
Total cell lysates were generated as above and proteins of interest were 
immunoprecipitated using Protein G Dynabeads (Invitrogen) and selected antibodies. 
  
Proximity Ligation Assays 
Human MKs were generated from CD34+ hematopoietic stem cells as stated in 
supplemental methods.  Proximity ligation assays (PLAs) were performed following 
the manufacturer’s protocol.  
 
Mice 
Adult animals were used including age-matched controls of the same genetic 
background. This study has been regulated under the Animals (Scientific Procedures) 
Act 1986 Amendment Regulations 2012 following ethical review by the University of 
Cambridge Animal Welfare and Ethical Review Body (AWERB) (Home Office 
PPL70/8406). A minimum of 5 different mice per experiment was used unless 
otherwise stated. 
 
Isolation of platelets 
Mouse blood was withdrawn from the inferior vena cava in either EDTA (5mM final) 
or ACD (111 mM glucose, 71 mM citric acid, 116 mM sodium citrate) while blood 
from GPS patients and controls was taken as previously reported 21. In both cases, 
platelets were washed using Tyrode’s buffer pH 6.5.  
 
Immunoblots 
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HEK, CHRF and platelets were lysed by addition of FTAP-lysis buffer (0.1% NP-40, 
150 mM NaCl, 10 mM Tris, pH 8) containing protease inhibitor cocktail and 
incubated on ice for 10 min before centrifugation at 13000 rpm for 15 min at 4ºC. 
  
Analysis of active Cdc42 and Rac1 
Platelets were washed as above and adjusted to 3x105 platelets/μL in Tyrode’s buffer 
pH 7.35. Stimulations with vehicle (PBS) and thrombin (T4648, Sigma, UK) were 
done at RT for different time points and lysis buffer provided by assay kit (BK127 
and BK128, Cytoskeleton, US) was added. Subsequent steps were carried out 
following the manufacturer’s protocol. Absorbance at 490 nm was read using an MP5 
plate reader (Molecular Devices, UK). 
 
F-actin formation in platelets 
Washed platelets were activated for 10 min and then fixed, permeabilized, incubated 
with 488-Phalloidin for 20 min and read in a Gallios flow cytometer (Beckman 
Coulter, UK). 
 
Platelet spreading on fibrinogen 
A solution of 100 μg/mL of fibrinogen (FIB3, Enzyme Research, UK) in PBS was 
used to coat coverslips (12392128, Thermo-Fisher Scientific) overnight at 4ºC. 
Platelets at 5x103/μL in Tyrode’s buffer pH 7.35 were seeded onto the coverslips and 
platelet agonists or vehicle were added.  
 
Transmission electron microscopy and gold-labeling  
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Cells were harvested, washed in physiological saline solution and fixed in 2% 
glutaraldehyde and 2% formaldehyde in 0.05M cacodylate solution, pH 7.4 for 4-6 
hours at 4ºC 27. Platelets were labelled as previously reported 34. 
 
Confocal microscopy 
Cells grown on coverslips were fixed with 2% paraformaldehyde-PBS for 30 min at 
RT and washed twice with PBS.  
 
Statistics 
Results are shown as mean ± SEM. Statistical analysis was performed using the 
unpaired Student’s t test. p-values<0.05 were considered statistically significant. 
 
A complete list of primary antibodies used in this study is provided in Table S1.  
 
RESULTS 
 
The Nbeal2 interactome 
To identify the putative interacting proteins of Nbeal2 (the interactome hereafter) a 
construct encompassing the PH, BEACH and WD40 (PBW) domains and a FLAG 
Tandem Affinity Purification (FTAP) tag 32 (Figure 1A) was used to transform HEK 
(Figure 1B), which endogenously express Nbeal2 (Figure S1A). An FTAP-tagged 
green fluorescent protein (GFP) construct was used as a control (Figure 1A and 1B). 
Cells were then used in a two-step (FLAG and calmodulin binding peptide) sequential 
affinity purification and the resulting eluate was separated by SDS-PAGE followed by 
mass spectrometry analysis (Figure 1C). Proteins identified in GFP samples and from 
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an “in-house contaminant” database as stated in Methods were removed from further 
analysis. The classification of the remaining 132 proteins (129 entries by gene name 
excluding NBEAL2; Table S2) according to the most frequent gene ontology terms 
shows an array of biological functions (Figure 1D).   
 
To better comprehend its functional role, we used the interaction data to embed 
Nbeal2 in a protein-protein interaction network (PPIN) representing the processes of 
hemostasis, megakaryopoiesis and platelet formation 35. The PPIN of 5,112 nodes 
(proteins) and 27,441 edges (biochemical interactions) was obtained by retrieving first 
order interactions from Reactome 36 and IntAct 37 using a set of 637 bait proteins 
(baits hereafter). The set of genes encoding the baits resulted from an integrative 
analysis of a genome wide association study (GWAS) for platelet traits in 173,480 
individuals 38,39 and a promoter capture Hi-C assay in human MKs 40; the 79 genes 
implicated in Mendelian disorders of hemostasis were also included 14,41. Of the 129 
nodes in the Nbeal2 interactome, 91 are present in the PPIN (orange nodes in Figure 
1E) and the remaining 38 are first order interactors with one or several proteins of the 
PPIN (purple nodes in Figure 1E). 
 
Previous studies on proteins from the BEACH family suggest that they may function 
as scaffolds with a critical role of Nbeal2 in homeostasis of α-granules 26,27,29. Based 
on this and on a detailed inspection of the PPIN, 10 candidate proteins were selected 
for validation studies by reverse immunoprecipitation (Table S2) and the interactions 
of three proteins were confirmed, namely Dock7 (a guanidine exchange factor 
[GEF]); Sec16a (an endoplasmic reticulum [ER] membrane protein); and Vac14 (a 
regulator of phosphatidyl inositol 3,5- bisphosphate [PtdIns[3,5]P2]) (triangular 
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orange nodes in Figure 1E). Their first order interactors are illustrated in the 
subnetworks in Figure 1F-1H (Figure S2-S4 for fully-labeled versions). 
 
Dock7, Sec16a and Vac14 interact with Nbeal2 
To confirm the interactions with Nbeal2, we firstly performed immunoprecipitation of 
the selected candidates in PBW-FTAP HEK and positive results for Dock7, Sec16a 
and Vac14 were obtained (Figure 2A and 2B). These experiments showed that 
endogenous Sec16a and Vac14 pulled-down PBW-FTAP and Dock7, and endogenous 
Dock7 pulled-down PBW-FTAP and Vac14 (Figure 2B, Figure S5). Assays in GFP-
FTAP HEK, as expected, showed no interactions with any of the three proteins 
(Figure 2C). Secondly, we used CHRF, which have a transcriptome reminiscent of 
MKs 42 and a robust Nbeal2 protein expression (Figure S1B). Lentiviral transduction 
with PBW-FTAP followed by the same experimental approach as used for HEK 
confirmed the interaction with Dock7, Sec16a and Vac14 in PBW-FTAP CHRF 
(Figure 2D). Furthermore, endogenous Nbeal2 was also detected when the three 
interactors were pulled-down in non-transduced CHRF, although the recovery levels 
for Dock7 and Sec16a were low (Fig 2E). Finally, after the initial successful 
validation experiments with cell lines, we used PLA in MKs derived from human 
hematopoietic stem cells 43. The two most abundant platelet membrane receptor 
complexes for fibrinogen (αIIbβ3 integrin) and Von Willebrand Factor (GPIbα,  
GPIbβ, GPV, GPIX) respectively were used to validate the assay. As expected, 
targeting αIIb and GPIX simultaneously produced a weak PLA signal similar to that 
using isotype controls, while targeting GPIbα and GPIX generated a strong signal 
(Figure 2F). When compared to the negative control, we observed a significant 
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increase in PLA signals in Dock7-Nbeal2 and Vac14-Nbeal2 labelled-MKs further 
supporting the interactions between these proteins (Figure 2F). 
 
Dock7 and Vac14, but not Sec16a bind the BEACH domain 
The BEACH domain intimately interacts with its adjacent amino-terminal PH domain 
over an interface of 1,300 Å2, suggesting they may fold as a single functional unit 
30,31
. We therefore overexpressed a construct comprising both the PH and BEACH 
domains (PB) in HEK (Figure 3A). Dock7 and Vac14 were present in PB-FTAP and 
PBW-FTAP pulldowns while Sec16a was recovered only with PBW-FTAP (Figure 
3B). Hence, the binding of Sec16a to Nbeal2 may be mediated through the WD40 
domain, whilst the other two proteins bind to either the PH and/or BEACH domain. 
 
Impact of GPS-causing variants on the interaction of Dock7 and Vac14 
To determine the possible effects of GPS-causing mutations we catalogued all 
reported missense variants (n=22) 21,23,44,45 and those identified “in-house” by the 
ThromboGenomics 41 and NIHR BioResource sequencing projects (n=14; 
unpublished). This showed a significant 5-fold enrichment (Fisher-test, p-
value=3.64x10-5) of variants in the BEACH domain, which harbored 13 of 36 of the 
observed variants (36%), whilst the domain only accounts for 292 of the 2,754 (11%) 
amino acids of Nbeal2. We used the coordinates of the crystal structure of the 
BEACH domain of Lrba (pdb 1T77) to estimate the functional consequences of the 13 
mutations and selected 6 with different types of structural changes to determine their 
effects on the binding of Dock7 and Vac14 (Figure 3C and 3D). HEK were stably 
transfected with PBW-FTAP constructs and the reference and five variant-carrying 
baits were expressed at similar levels, indicating a minimal, if any, detrimental effect 
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of each variant on the folding of the domains (Figure 3E). Our results showed that 
M2080K, P2100L and G2290W/E2294G (both on the same haplotype) seemed to 
diminish the binding of Vac14 (Figure 3E), P2100L and R2172H significantly 
reduced Dock7 binding and its binding to the G2290W/E2294G bait seemed to be at a 
reduced level, although the difference with the reference bait was not significant 
(Figure 3F).   
 
Localization of PBW-FTAP and Nbeal2 by electron and confocal microscopy 
Currently, the subcellular localization of Nbeal2 remains unknown. We investigated 
this using PBW-FTAP CHRF by labeling its FLAG epitope. Transmission electron 
microscopy revealed the presence of intracellular vesicles, mitochondria and Golgi in 
CHRF (Figure 4A and 4B). Labeling of FLAG by gold-adsorbed immunoglobulins 
did not show any staining in CHRF (not shown). However, clusters of gold were 
observed across the cytoplasm of PBW-FTAP CHRF suggesting a cytosolic 
localization of PBW (Figure 4C-4F). This pattern was also confirmed by confocal 
microscopy by labeling PBW and F-actin with anti-FLAG and Phalloidin, 
respectively (Figure 4G and Figure S6). The use of a rabbit antiserum revealed the 
presence of Nbeal2 in the cytoplasm (arrowheads), in close proximity to enclosing 
membranes of the α-granules (arrows), the open canalicular system (OCS) (circles) 
and the cell surface (flat ellipses) of human platelets (Figure 4H). 
 
Subcellular localization of Nbeal2, Dock7, Sec16a and Vac14 in platelets 
We further investigated the localization of Nbeal2 and its interactors Dock7, Sec16a 
and Vac14 by subcellular fractionation of platelets. We firstly fractionated human 
platelets and identified cytoskeleton and dense tubular system (DTS) in fractions 1 to 
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4 (enriched for tubulin, actin and calreticulin) and α-granules in fraction 7 and 8 
(enriched for the α-granule protein Thrombospondin-1 [Thbs1]) (Figure 5A). Nbeal2 
was mostly found in fractions 2-4 containing cytoskeletal and DTS proteins (Figure 
5A). Fractionation of murine platelets showed a similar pattern, i.e. Nbeal2 was 
primarily found in fractions 3-4 (Figure 5B). As expected, proteins typically stored in 
α-granules, Thbs1 and vascular endothelial growth factor (Vegf), are significantly 
reduced in GPS platelets (Figure 5B). Dock7 was present in the α-granule-containing 
fraction (7-8) of control platelets but was mislocalized in fraction 4 in Nbeal2-/- 
platelets (Figure 5C). Although at lower levels, Dock7 and Nbeal2 colocalize in 
fractions 3-4 and 7-8, respectively, providing further evidence of their interaction 
(Figure S7). The localization of Sec16a and Vac14 did not differ significantly 
between platelets from both groups (Figure 5D and 5E), despite potential apparent 
increased levels of Sec16a in Nbeal2-/- platelets (Figure 5D), an observation which 
was not replicated in whole platelet lysates (Figure 5F and 5G). 
Having identified the impact of the absence of Nbeal2 on the subcellular localization 
of Dock7, we then asked whether it had an effect on the overall cellular abundance of 
the three interactors. Similar levels of Sec16a and Vac14 were confirmed in platelets 
from both groups, but the Dock7 protein level was significantly reduced in Nbeal2-/- 
platelets (Figure 5F, 5G and Figure S8), and importantly, also in the platelets of two 
GPS cases (Pedigree C of previous report 21) (Figure 5H). Transcript levels of Dock7 
in mouse MKs did not differ significantly between control and Nbeal2-/- mice (27 and 
Table S3) and immunoblots with anti-Dock7 did not reveal signs of proteolysis or 
higher Dock7 levels in plasma (not shown), suggesting that the Nbeal2 protein is 
likely involved in its post-translational modification and/or stability.  
 
For personal use only.on January 12, 2018. by guest  www.bloodjournal.orgFrom 
Mayer et al 
 15
The Dock7 signaling pathway is altered in Nbeal2-/- platelets 
As a GEF, Dock7 exchanges GDP for GTP on Cdc42 and Rac1 causing their 
activation, followed by activation of downstream effectors including the 
dephosphorylation (activation) of cofilin, a key regulator of actin turnover 46,47. Actin 
reorganization then leads to extension of filopodia and generation of lamellipodia 46, 
ultimately resulting in platelet shape change. Given the significant reduction of Dock7 
levels and its altered localization in Nbeal2-/- platelets, we postulated that this 
canonical signaling pathway may be disrupted and set out to test this using control 
and Nbeal2-/- platelets. 
Firstly, the phosphorylated (inactive) form of cofilin, P-cofilin, was significantly 
increased in murine Nbeal2-/- platelets (Figure 6A and 6B). Other regulators of this 
signaling pathway such as Cdc42, Rac1, Iqgap1 and chronophin 46,48 were also 
measured and we found that the level of Iqgap1, a protein that stabilizes the active 
forms of Cdc42 and Rac1, was also significantly higher in Nbeal2-/- platelets (Figure 
6A and 6B) suggesting that the increase in P-cofilin was likely due to an imbalance 
not only of Dock7 but also of Iqgap1. In fact, our previous gene expression array of 
control and Nbeal2-/- MKs revealed a significantly increased Iqgap1 transcript level in 
the latter (27 and Table S4), which is validated at the protein level in platelets in this 
study.  
We then asked if the disequilibrium in the Dock7/Iqgap1/P-cofilin pathway had an 
effect on the function of platelets. Firstly, levels of active Rac1 at 2 min after 
activation by thrombin were significantly higher  (p-value=0.026) in platelets from 
control versus Nbeal2-/- mice and a similar trend was observed for Cdc42, but this did 
not reach significance (Figure 6C and 6D). Secondly, we measured F-actin formation 
in platelets. Despite higher levels of F-actin in basal Nbeal2-/- platelets due to their 
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larger size (Figure 6E, p-value=0.048), induction of actin polymerization by thrombin 
revealed a lower increase in Nbeal2-/- platelets (Figure 6E and 6F, p-value=0.0005). 
At last, we checked the endpoint of this pathway i.e. platelet shape change by 
measuring the ability of platelets to spread onto fibrinogen after activation with both 
ADP and thrombin. Enumeration of activated versus non-activated platelets assessed 
by shape-change and spreading revealed that nearly all control platelets became 
activated while the Nbeal2-/- platelets showed significantly reduced spreading (Figure 
6G and 6H, p-value=<0.0005).  Altogether, these results are compatible with the 
notion that Nbeal2 plays an important role in the regulation of cytoskeletal 
rearrangements in platelets, most likely through its interaction with Dock7. 
 
Discussion 
 
Despite the severity of inherited granule pathologies caused by mutations in NBEAL2, 
NBEA and LYST, the key roles of the encoded BEACH proteins in the ontogeny of α-, 
δ- and lysosomal granules remain poorly defined. Here we report the results of studies 
aiming at defining the role of Nbeal2 at the biochemical and cellular level. 
 
We identified the putative interactors of Nbeal2 in human cells and selected 10 
candidate interactors for validation. The interactions of Dock7, Sec16a, and Vac14 
with Nbeal2 were confirmed and the physical proximity of the former two to Nbeal2 
in human MKs was corroborated by PLA. Furthermore, the introduction of GPS-
causing mutations in the BEACH domain showed profound effects on the interactions 
with Dock7. While Nbeal2 is mostly present in the platelet cytoplasm, Dock7 
localizes to the α-granules and, interestingly, murine and human platelets devoid of 
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functional Nbeal2 showed strongly reduced Dock7 levels resulting in changes in its 
canonical signaling pathway.  
 
The 5-fold enrichment of GPS-causing variants in the BEACH domain prompted us 
to perform the pull-downs with a construct containing the BEACH and its PH and 
WD40 flanking domains. Despite the potential presence of false-positive interactors, 
frequently seen in proteomics assays, 70% of the 129 proteins in Nbeal2’s 
interactome are present as primary nodes in the PPIN, which represents a lion’s share 
of the proteome of human MKs. So far no similar interaction data are available for 
any of the BEACH proteins, except for the 21 proteins possibly interacting with Lyst 
49
.  
 
The observation that Nbeal2 localizes in the vicinity of the membrane, OCS and α-
granules of platelets is compatible with its assumed role in membrane dynamics, and 
especially α-granule trafficking. Our results are supportive of the notion that the GEF 
Dock7 may be a critical intermediary in this membrane dynamics, which is also 
essential in the formation of platelets by MKs 46. Therefore, the discovery that Dock7 
is nearly depleted from platelets of GPS cases and Nbeal2-/- mice provides a plausible 
explanation why these platelets have an increased volume. In addition, our GWAS 
identified variants associated with platelet traits in nine genes encoding proteins in the 
Nbeal2 interactome (Nbeal2 itself, Dock7 and the seven circular orange nodes with 
appended gene names in Figure 1E). The variant rs60286666 in DOCK7 is associated 
with the distribution width of platelet volume (p-value= 8.59x10-33) providing further 
evidence of this Nbeal2 interactor possibly being important in the formation of 
platelets by MKs39. The role of Dock7 in platelet function has not been studied, but 
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the misty mouse, with a truncation in Dock7, has a prolonged bleeding time possibly 
explained by a reduced ability of platelets to support hemostasis 50. The relevance of 
the canonical Rac1/Cdc42/Dock7 signaling pathway in megakaryopoiesis and platelet 
function has however been extensively studied. The conditional deletion of cofilin 51 
and simultaneous deficiency of Rac1 and Cdc42 52 result in decreased platelet count, 
larger platelets, and impairment of their function including defective shape change. 
Moreover, dysregulation of cofilin was also observed in a mouse knock-in and a 
family with type 2B von Willebrand disease, both presenting with 
macrothrombocytopenia 53. Similar to these reports, we show that several elements of 
this signaling pathway, i.e. P-cofilin and Iqgap1 (a stabilizer of the active form of 
Cdc42 and Rac1) are dysregulated in murine Nbeal2-/- platelets, probably as a 
consequence of the reduced levels of Dock7. Hence, GTP-Rac1 levels are diminished 
in thrombin-stimulated Nbeal2-/- platelets, which show reduced actin polymerization 
and are unable to change shape efficiently (Figure 6D-H). Indeed, taken all the above 
evidence together, it is reasonable to assume that the macrothrombocytopenia in 
Nbeal2-/- mice and in GPS cases, is in part explained by the specific loss of Dock7.  
 
Dock7 interacts with the PH-BEACH domain and this interaction seems to be 
diminished by all but one of the six GPS-causing mutations surveyed (Figure 3F). It 
has been suggested that Dock7 or one of its binding partners is localized in or on the 
surface of α-granules, and its PIP2/PIP3 binding domain makes the latter more likely 
54
. Our results are supportive of this assumption and we reason that the interaction of 
Dock7 and α-granules is mediated through the BEACH domain.  
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Sec16a defines the budding sites on the ER membrane for trafficking of vesicles 
through the Golgi 55 and disruption of its binding to mutant WD40 domains (Figure 
3B) could potentially affect platelet homeostasis. Similarly, changes in the function of 
Vac14, which in complex with Fig4 and Pikfyve (Figure 1H) regulates the levels of 
PI(3-5)P2, may alter endosomal trafficking and signaling 56.  
 
In summary, from 129 binding partners of Nbeal2 identified by mass spectrometry, 
we have confirmed the interaction of three, Dock7, Sec16a and Vac14, by different 
biochemical and cellular approaches; and have also studied the functional relevance 
of one, Dock7, in platelet biology and its involvement in the abnormal formation of 
platelets by megakaryocytes in Gray Platelet Syndrome.  
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Figure legends 
 
Figure 1. The Nbeal2 interactome. (A) Diagram showing the functional domains of 
Nbeal2 (ARM, Armadillo; ConA, Concanavalin A; WD40 repeat (WD40); PH, 
Pleckstrin homology; BEACH, Beige and Chediak Higashi domains). Construct 1 
(PBW-FTAP) encompasses the PH, BEACH and amino-terminal WD40 domains and 
the FLAG Tandem Affinity Purification (FTAP) tag. Construct 2 (GFP-FTAP) 
encompasses Green Fluorescent Protein (GFP) and FTAP. (B) Ectopic expression of 
GFP-FTAP and PBW-FTAP in HEK. (C) FTAP-purification of GFP-FTAP and 
PBW-FTAP from HEK. Purified proteins were resolved by SDS-PAGE, visualized by 
blue Coomassie stain and analyzed by liquid chromatography-mass spectrometry. 
Some lanes in gels from panel B and C were deleted and replaced by black vertical 
lines. (D) Identified proteins (n=129) were classified according to their protein class 
using gene ontology terms. (E) Protein-protein interaction network (PPIN); 637 bait 
proteins representing the processes of hemostasis, megakaryopoiesis and platelet 
formation were used to retrieve 5,112 nodes (proteins) and 26,702 edges (biochemical 
reactions) by Reactome and IntAct. Orange nodes (n=91) are interactors present in the 
PPIN and the purple nodes (n=38) have interactions with one or more proteins of the 
PPIN. Nbeal2 is shown in black and Dock7, Sec16a, Vac14 are shown as orange 
triangles. (F-H) Subnetworks extracted from the PPIN in E for Dock7 (F), Sec16a (G) 
and Vac14 (H). The expression levels for the corresponding genes determined by the 
sequencing of RNA of human megakaryocytes (MKs) and expressed as log2 FPKM 
(Fragments Per Kilobase of transcript per Million mapped reads) is presented in 
white-to-green color and only nodes corresponding to genes with FPKM>1 in MKs 
are depicted (see color bar for relative FPKM values) 43.  
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The grey/black (1E-H), light blue (1F-1H) and dark blue (1F-1H) edges are based on 
the results of pulldown experiments reported in this study, Reactome and IntAct, 
respectively. 
A Cytoscape file to generate an interactive version of the PPIN, containing gene 
expression levels and other annotation features is available from the data supplement. 
 
Figure 2. Dock7, Sec16a and Vac14 interact with Nbeal2. (A-B) 
Immunoprecipitation (IP) of Dock7, Sec16a and Vac14 from PBW-FTAP HEK with 
total cell lysate (input) in A, IP results in B. PBW-FTAP was detected by anti-FLAG 
and a rabbit isotype IgG was used as control. Immunoblot with specific antibodies 
against Dock7, Sec16a and Vac14 (top blot in B). The other three blots in B show the 
specific binding of each of the cognate antibodies and the results with the isotype 
control immunoglobulin (ct-IgG) are in the first lane of the four blots in B. (C)-(E) 
Similar IP assays as in A carried out with HEK (C) or CHRF (D and E). (F) Proximity 
Ligation Assays (PLA) with human MKs showing the results for 1) αIIb and GPIX as 
negative control (top-left), 2) GPIbα and GPIX as positive control (top-middle), 3) 
Sec16a (top-right); Vac14 (two bottom-left); and Dock7 (two bottom-right), each 
interactor was tested in combination with Nbeal2. Interactions between proteins are 
presented as orange dots and cells were counterstained with Phalloidin (green) and 
DAPI (blue). 4) Quantitative analysis of the number of interactions per cell surface 
based on analysis of the PLA signals by Image Studio are presented in the bar graph. 
Comparisons were made against the negative control. Bars represent mean±SEM. * 
denotes p-value <0.05. 
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Figure 3. Effect of missense variants in the BEACH domain identified in Gray 
Platelet Syndrome cases on the interaction with Dock7 and Vac14. (A) Diagram 
representing the construct PB-FTAP including the PH and BEACH domains of 
Nbeal2 and the FTAP-tag. (B) HEK whole cell lysates containing a mixture of PB-
FTAP and PBW-FTAP in a 1:1 ratio, or only PB-FTAP and PBW-FTAP (input) were 
immunoprecipitated (IP) using an isotype control IgG (Ct-IgG) or anti-FLAG. (C) 
Diagram representing the functional domains of Nbeal2 as per Figure 1A. Six amino 
acid mutations causative of Gray Platelet Syndrome (GPS) were selected on basis of 
their predicted functional consequences. (D) Computer model of the BEACH domain 
illustrating the six mutations shown in C and color-classified by disruptive effect. (E) 
PBW-FTAP in HEK expressing the reference allele or the six mutations were lysed 
(input), IP with anti-FLAG and blotted with anti-Vac14. Quantitation of the 
interaction Vac14-Nbeal2 for each of the variants and control was achieved by 
densitometry. (F) Similar assays performed in E but immunoblots were developed 
with anti-Dock7. Experiments were performed on five independent occasions. Bars 
represent mean±SEM. * denotes p-value<0.05. 
 
Figure 4. Subcellular localization of PBW-FTAP and Nbeal2. (A) Ultrastructure of 
PBW-FTAP in CHRF by transmission electron microscopy (TEM). (B) High 
magnification of the area squared in A showing intracellular vesicles (V), 
mitochondria (M), Golgi and the nucleus (N). (C) Indirect gold-labeling of PBW-
FTAP using anti-FLAG. Arrowheads point to clusters of gold across the cytoplasm of 
CHRF. (D) High magnification of the boxed area in C. (E) PBW-FTAP in CHRF 
stained as in C showing gold clusters in the cytoplasm but not in the intracellular 
vesicles. (F) High magnification of the boxed area in E. (G) Labeling of F-actin 
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filaments with Phalloidin (top panel), PBW-FTAP (middle panel) and overlay 
(bottom panel) of the results from top and middle panels, visualized by confocal 
microscopy; nucleus stained with DAPI. Scale bar represents 10 μm. (H) Gold-
labeling of Nbeal2 in human platelets with rabbit antiserum. Gold particles label the 
platelet cytoplasm (arrowheads), α-granules (arrows), open canalicular system 
(circles) and periphery (flat ellipses). Images are representative of the results of two 
TEM, one (gold-labeling) and three (confocal microscopy) independent experiments.  
  
Figure 5. Subcellular localization of Nbeal2 and its interactors, Dock7, Sec16a 
and Vac14 in platelets. (A) and (B) SDS-PAGE separated fractions 1-12 obtained by 
sucrose gradient centrifugation of human (A) and murine (B) platelets probed in 
immunoblots (IB) with specific antibodies against Nbeal2, Thbs1 (Thrombospondin-
1), Crn (Calreticulin), Tuba1c (Tubulin Alpha 1c), and Actin (β-actin); for the murine 
platelets Crn was not probed but a specific antibody against Vegf (vascular 
endothelial growth factor) was included. (C)-(E) Localization of Nbeal2 interactors by 
IB in the different fractions obtained from platelets of control and Nbeal2-/- mice, (C) 
Dock7 in fraction 7-8 and fractions 3-4, respectively; (D) Sec16a in fraction 1-4; (E) 
Vac14 in fraction 5. (F) Levels of Nbeal2, Dock7, Sec16a and Vac14 in platelets from 
control and Nbeal2-/- mice. (G) Densitometry of the Western blot results shown in F; 
total lysates from F were performed on platelets of at least 4 (Nbeal2, Sec16a, Vac14) 
and 8 (Dock7) mice per genotype group. (H) Levels of Dock7 in platelets from Gray 
Platelet Syndrome (GPS) cases. For experiments in (G) and (H) Gapdh was used as a 
loading control and levels of the other proteins were normalized to Gapdh. Bars 
represent mean±SEM. * denotes p-value<0.05.  
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Figure 6. The Dock7 signaling pathway is altered in Nbeal2-/- platelets. (A) 
Platelet lysates from control and Nbeal2-/- mice were resolved by SDS-PAGE and 
expression levels of Rac1, Cdc42, cofilin, P-cofilin, Iqgap1, Pdxp and Gapdh were 
observed by immunoblot (IB) with specific antibodies. (B) Densitometry of the 
results of the blots shown in A using Image Studio. (C) and (D) Time course of active 
Cdc42 (GTP-Cdc42) and active Rac1 (GTP-Rac1) in platelets stimulated with 0.5 
U/mL thrombin. (E) F-actin levels in resting and thrombin-activated platelets. (F) 
Relative increase in F-actin levels in thrombin-activated vs resting platelets of control 
and Nbeal2-/- mice.  (G) Representative images of platelets spreading on fibrinogen in 
response to thrombin from control and Nbeal2-/- mice at different magnifications. (H) 
Quantitation of fully spread and round platelets from control and Nbeal2-/- mice in 
response to activation with thrombin or ADP. Platelets in five random fields per 
condition were counted, with each field having between 80-120 platelets; four 
animals per genotype group were used. Bars represent mean±SEM. *, ** and *** 
denote p-values <0.05, <0.005 and <0.0005, respectively. 
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